Daniel Vukas, MD
Otolaryngology · Munster, INNPI 1013993005
Payments from drug & device makers
Across 42 payments — averaging $28.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$244
- Medtronic$150
- Stryker$148
- Optinose US, Inc.$128
- Sanofi$96
- Smith+Nephew$92
- plus $355 from 8 others
What the payments were for
- Consulting fees$15012%
- Food & beverage$1,06388%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 7 | $244 |
| Medtronic | 1 | $150 |
| Stryker | 6 | $148 |
| Optinose US, Inc. | 7 | $128 |
| Sanofi | 3 | $96 |
| Smith+Nephew | 4 | $92 |
| Acclarent, Inc | 2 | $91 |
| Itamar Medical Inc | 2 | $53 |
| GSK | 3 | $47 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
| Alk-abello, Inc | 2 | $43 |
| Integra Lifesciences Corporation | 1 | $26 |
| Checkpoint Surgical, Inc | 1 | $25 |
| Cochlear Americas | 1 | $23 |
How this compares
$1,213 in reported general payments places this provider in the 45th percentile of 193 otolaryngology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 271 | $3,859 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 30 | $3,467 |
| Sucralfate | 13 | $986 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 18 | $766 |
| Azelastine Hcl | 47 | $717 |
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 18 | $667 |
| Cefdinir | 14 | $598 |
| Omeprazole | 22 | $315 |
| Pantoprazole Sodium | 24 | $201 |
| Methylprednisolone | 30 | $137 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $88 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $79 |
| Mometasone Furoate | 13 | $58 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Munster
- Anil ShahMunster$17K
- Inna HusainMunster$13K
- Kedar KakodkarMunster$7K
- Scott PhillipsCarmel$2.2M
- Joshua GreeneAnderson$1.1M
- Venkata KakarlapudiNew Albany$175K
- Colin NeumannNew Albany$135K
- Noah ParkerCarmel$133K
- Tod HuntleyCarmel$124K
- Satyan SreenathIndianapolis$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.